US generics firm Akorn is searching for a new CEO in the wake of a failed merger with Fresenius Kabi last year.
Camuto Group was a portfolio position at 9/30/2018. GARS had $8.9mn first lien position, with a yield of 7.5%. The position was Performing. The loan was only booked in IIQ 2018 and based on IIIQ 2018 valuation at premium to cost a pre-payment or other fee is likely as a result of the transaction, probably around $0.200mn.